( SAN DIEGO--(BUSINESS WIRE)--Jul 2 2007...)Accelrys to Present to Investors at C.E. Unterberg Emerging Growth,Opportunities Conference,Health

SAN DIEGO--(BUSINESS WIRE)--Jul 2, 2007 - Accelrys, Inc. (NASDAQ:ACCL), the leading provider of scientific business intelligence software and services, announced today that its CFO, Rick Russo, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference in New York on July 11, 2007 at 10:30 a.m. ET. The conference will take place at the Mandarin Oriental Hotel July 10th-12th. In attendance will be securities analysts, fund managers, and institutional investors.

The company will host a live web cast of the conference presentation at 10:30 a.m. ET on Wednesday, July 11, 2007. This web cast can be accessed through the Investor Relations section of Accelrys' web site at www.accelrys.com or by visiting the following web address: http://www.wsw.com/webcast/ceut6/accl/.

To learn more about C.E. Unterberg, Towbin, please visit www.unterberg.com.

About Accelrys, Inc.

Accelrys develops and commercializes Scientific Business Intelligence(TM) software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data. Our solutions are used by biologists, chemists, materials scientists, and information technology professionals for product design as well as drug discovery and development. Our technology and services are designed to meet the needs of today's leading research and development organizations including leading commercial, government and academic organizations. Many of the largest pharmaceutical, biotechnology, chemical, and petroleum companies worldwide use our solutions. Accelrys is headquartered in San Diego, California. For more information about Accelrys, visit its website at http://www.accelrys.com/.

Contact

Accelrys, Inc.
Philomena Walsh, 858-799-5440
pwalsh@accelrys.com
or
MKR Group, Inc.
Todd Ke
'"/>

Page: 1 2
Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference